> top > docs > PMC:7784786 > spans > 11810-12264 > annotations

PMC:7784786 / 11810-12264 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
412 6-14 Species denotes patients Tax:9606
413 446-453 Species denotes patient Tax:9606
414 153-163 Chemical denotes itolizumab MESH:C000597346
415 33-41 Disease denotes COVID-19 MESH:C000657245
416 56-70 Disease denotes critically ill MESH:D016638
417 326-334 Disease denotes COVID-19 MESH:C000657245

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T108 0-244 Sentence denotes Three patients with diagnosis of COVID-19 classified as critically ill (two) and severely ill (one) were included in an expanded access trial to receive itolizumab in addition to standard treatment (http://rpcec.sld.cu/trials/RPCEC00000311-En).
T109 245-379 Sentence denotes The study was approved by a central ethical review board, created especially for COVID-19 and by the Cuban Regulatory Agency (CECMED).
T110 380-454 Sentence denotes Before the treatment, informed consent was obtained from enrolled patient.